Allianz Asset Management GmbH - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 60 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2019$44,467,000
-39.3%
33,305,000
-51.9%
0.04%
-45.0%
Q4 2018$73,300,000
-15.1%
69,305,000
-15.0%
0.08%
+2.6%
Q3 2018$86,330,000
-2.4%
81,540,000
-9.5%
0.08%
-9.3%
Q2 2018$88,414,000
+61.6%
90,050,000
+65.1%
0.09%
+65.4%
Q1 2018$54,716,000
-14.8%
54,550,000
-9.9%
0.05%
+2.0%
Q4 2017$64,231,000
+3.0%
60,525,000
+3.0%
0.05%
-5.6%
Q3 2017$62,385,000
+25.5%
58,745,000
+25.9%
0.05%
+12.5%
Q2 2017$49,704,000
-17.3%
46,645,000
-25.1%
0.05%
-18.6%
Q1 2017$60,093,000
-22.7%
62,245,000
-17.5%
0.06%
-15.7%
Q4 2016$77,696,000
+21.8%
75,450,000
+10.2%
0.07%
+12.9%
Q3 2016$63,810,00068,450,0000.06%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q1 2019
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 83,741,000$95,429,0006.49%
STEELHEAD PARTNERS LLC 52,496,000$59,911,0005.47%
SILVERBACK ASSET MANAGEMENT LLC 23,000,000$26,278,0004.02%
Castle Creek Arbitrage, LLC 10,734,000$12,253,0003.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,132,000$45,920,0002.81%
Sonora Investment Management, LLC 16,707,000$19,084,0001.99%
TFG Asset Management GP Ltd 8,500,000$9,718,0001.73%
Verition Fund Management LLC 27,901,000$31,890,0000.88%
SSI INVESTMENT MANAGEMENT LLC 7,872,000$8,977,0000.65%
SHENKMAN CAPITAL MANAGEMENT INC 4,780,000$5,514,0000.63%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders